FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1151.21.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.21/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21
Version20170216
Statusactive
Date2017-02-16T01:00:02-05:00
NameCalcineurinInhibitorsForPatientsReceivingUrologyCare
TitleCalcineurin inhibitors for patients receiving Urology Care
Realmus
Authorityhl7
Purpose(Clinical Focus: Calcineurin inhibitors for patients receiving urology care.),(Data Element Scope: This data element is to define immunosuppresssive therapy in patients receiving urology care.),(Inclusion Criteria: Patients on calcineruin inhibitors.),(Exclusion Criteria: Patients not on calcineurin inhibitors.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
sctSNOMED codes used in this IG

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1151.21",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Oregon Urology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-02-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2017-02-16"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.21",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1151.21"
    }
  ],
  "version": "20170216",
  "name": "CalcineurinInhibitorsForPatientsReceivingUrologyCare",
  "title": "Calcineurin inhibitors for patients receiving Urology Care",
  "status": "active",
  "experimental": false,
  "date": "2017-02-16T01:00:02-05:00",
  "publisher": "Oregon Urology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: Calcineurin inhibitors for patients receiving urology care.),(Data Element Scope: This data element is to define immunosuppresssive therapy in patients receiving urology care.),(Inclusion Criteria: Patients on calcineruin inhibitors.),(Exclusion Criteria: Patients not on calcineurin inhibitors.)",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "416587008",
            "display": "Calcineurin inhibitor (product)"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:5df21df9-563f-4100-a7a5-57a3a8a0c57e",
    "timestamp": "2025-05-23T18:58:27-04:00",
    "total": 1,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "416587008",
        "display": "Product containing calcineurin inhibitor (product)"
      }
    ]
  }
}